Effect of intestinal microbiome diversity on the efficacy and survival of chemotherapy for advanced non-small cell lung cancer

ABSTRACT: Interventions: Response Group:none;None Response Group:Nil Primary outcome(s): CR;PR;SD;PD;PFS;OS;Gut microbiome;Fecal metabolomics;Immune factor Study Design: Factorial

DISEASE(S): Non-small Cell Lung Cancer

PROVIDER: 2689133 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR